| Amgen's EPO Drugs Dodge a Bullet as Hematide Stumbles, but the Big Biotech's ... - BNET |
|
|
BNETA subgroup analysis of anemia patients not yet on dialysis showed more cardiovascular side effects with Hematide. In one trial, patients on Hematide needed ... read more |